(6S,8S,9R,10S,11S,13S,14S)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
| Product Name |
(6S,8S,9R,10S,11S,13S,14S)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
|
| Product Code |
DA-H001-c
|
| Chemical name |
(6S,8S,9R,10S,11S,13S,14S)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
|
| Synonyms |
NA
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C22H25ClF2O3
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
410.89
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
steroids,impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
NA
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |